Lineage Cell Therapeutics, Inc. (TLV: LCTX)
Israel
· Delayed Price · Currency is ILS · Price in ILA
317.90
-6.10 (-1.88%)
Oct 15, 2024, 5:24 PM IDT
Lineage Cell Therapeutics Revenue
Lineage Cell Therapeutics had revenue of $1.41M USD in the quarter ending June 30, 2024, a decrease of -56.34%. This brings the company's revenue in the last twelve months to $6.19M, down -41.22% year-over-year. In the year 2023, Lineage Cell Therapeutics had annual revenue of $8.95M, down -39.16%.
Revenue (ttm)
$6.19M
Revenue Growth
-41.22%
P/S Ratio
n/a
Revenue / Employee
$82.48K
Employees
75
Market Cap
591.68M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 8.95M | -5.76M | -39.16% |
Dec 31, 2022 | 14.70M | 10.36M | 238.70% |
Dec 31, 2021 | 4.34M | 2.52M | 137.73% |
Dec 31, 2020 | 1.83M | -1.69M | -48.05% |
Dec 31, 2019 | 3.52M | -1.47M | -29.53% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition